New Approaches for the Secondary Prevention of Cryptogenic Stroke Using Non-vitamin K Antagonist Oral Anticoagulants
Non-vitamin K antagonist oral anticoagulants (NOACs) were introduced to prevent systemic embolism in patients with non-valvular atrial fibrillation (AF), and the use of NOACs for secondary prevention of cardioembolic stroke in patients with AF has gradual
- PDF / 3,930,430 Bytes
- 101 Pages / 439.43 x 683.15 pts Page_size
- 77 Downloads / 260 Views
For Prevention of Stroke Masaaki Uno Kuniaki Ogasawara Editors
123
Treatment of Non-vitamin K Antagonist Oral Anticoagulants
Masaaki Uno • Kuniaki Ogasawara Editors
Treatment of Non-vitamin K Antagonist Oral Anticoagulants For Prevention of Stroke
Editors Masaaki Uno Department of Neurosurgery Kawasaki Medical School Kurashiki, Japan
Kuniaki Ogasawara Department of Neurosurgery Iwate Medical University Morioka, Japan
ISBN 978-981-10-1877-0 ISBN 978-981-10-1878-7 DOI 10.1007/978-981-10-1878-7
(eBook)
Library of Congress Control Number: 2016957749 © Springer Science+Business Media Singapore 2017 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. Printed on acid-free paper This Springer imprint is published by Springer Nature The registered company is Springer Nature Singapore Pte Ltd. The registered company address is: 152 Beach Road, #22-06/08 Gateway East, Singapore 189721, Singapore
Preface
I am pleased to present this new textbook, which is targeted at neurologists, neurosurgeons, and doctors who have an interest in stroke. In the pages that follow, information is presented regarding the use of non-vitamin K antagonist oral anticoagulants (NOACs) in stroke patients with a variety of impairments. In this textbook, the mechanisms, treatment strategies, recurrence rates, outcomes, and complications among stroke patients treated with NOACs are discussed by a variety of different authors. New findings regarding stroke patients in Japan are also included, along with a review of related data from all over the world. It is hoped that readers of this textbook will find not only interesting but also helpful information that can be applied in practice in their own hospitals and clinics. Because the prevalence of nonvalvular atrial fibrillation (NVAF) is increasing around the world, current information and new findings regarding NOACs should be made available to doctors who treat stroke patients with NVAF. I hope that this textbook will serve such a purpose. Finally, I wou
Data Loading...
